Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China · Delayed Price · Currency is CNY 82.15
+4.46 (5.74%)
At close: Mar 6, 2026
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 21.75 billion as of March 6, 2026. Its market cap has increased by 26.60% in one year.
Market Cap
21.75B
Enterprise Value
20.78B
Revenue
812.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
82.15
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 21.75B, an increase of 21.47%. That is a compound annual growth rate of 3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 21.75B | -11.38% |
| Dec 31, 2025 | 24.54B | 48.77% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xiamen Amoytop Biotech | 28.94B |
| Hualan Biological Engineering | 27.38B |
| Yili Chuanning Biotechnology | 24.37B |
| DaShenLin Pharmaceutical Group | 22.11B |
| BrightGene Bio-Medical Technology | 17.37B |
| Sinocelltech Group | 16.43B |
| Jinyu Bio-technology | 16.25B |
| Anhui Anke Biotechnology (Group) | 15.52B |